The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Lumpectomy Therapy Market Research Report 2025
Synopsis
A lumpectomy is a form of breast-conserving and preservation surgery used for the removal of breast tumor or some surrounding tissues. It is also known as a partial mastectomy because a part of breast tissue is removed in this procedure, whereas in mastectomy, the full breast is removed to avoid chances of cancer development in future.
The global Lumpectomy Therapy market was valued at US$ 1600 million in 2023 and is anticipated to reach US$ 2360.2 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
The lumpectomy therapy market is primarily driven by the increasing incidence of breast cancer and the growing preference for breast-conserving surgeries like lumpectomies over mastectomies. Patients often choose lumpectomies due to the potential for less physical and emotional trauma. Additionally, advancements in surgical techniques and technologies are enhancing the success rates of lumpectomies, further boosting their demand. However, challenges in this market include the need for comprehensive post-surgery care, including radiation therapy, to reduce the risk of cancer recurrence. Access to such therapies and their associated costs can be barriers for some patients. Moreover, ensuring complete tumor removal during lumpectomies is essential, and surgeons must strike a balance between conserving breast tissue and achieving optimal cancer treatment outcomes. These challenges highlight the importance of continued research and advancements in lumpectomy therapies to address the complex needs of breast cancer patients effectively.
This report aims to provide a comprehensive presentation of the global market for Lumpectomy Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lumpectomy Therapy.
Report Scope
The Lumpectomy Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lumpectomy Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lumpectomy Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hologic
BD
Danaher
Cook Medical
Carl Zeiss Meditech
Merit Medical
Argon Medical Devices
Eckert & Ziegler
Theragenics
Sanarus
IsoAid
SOMATEX Medical
Ranfac
STERYLAB
Endomagnetics
Segment by Type
Lumpectomy Systems
Lumpectomy Surgical Tools
Segment by Application
Hospitals
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lumpectomy Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A lumpectomy is a form of breast-conserving and preservation surgery used for the removal of breast tumor or some surrounding tissues. It is also known as a partial mastectomy because a part of breast tissue is removed in this procedure, whereas in mastectomy, the full breast is removed to avoid chances of cancer development in future.
The global Lumpectomy Therapy market was valued at US$ 1600 million in 2023 and is anticipated to reach US$ 2360.2 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
The lumpectomy therapy market is primarily driven by the increasing incidence of breast cancer and the growing preference for breast-conserving surgeries like lumpectomies over mastectomies. Patients often choose lumpectomies due to the potential for less physical and emotional trauma. Additionally, advancements in surgical techniques and technologies are enhancing the success rates of lumpectomies, further boosting their demand. However, challenges in this market include the need for comprehensive post-surgery care, including radiation therapy, to reduce the risk of cancer recurrence. Access to such therapies and their associated costs can be barriers for some patients. Moreover, ensuring complete tumor removal during lumpectomies is essential, and surgeons must strike a balance between conserving breast tissue and achieving optimal cancer treatment outcomes. These challenges highlight the importance of continued research and advancements in lumpectomy therapies to address the complex needs of breast cancer patients effectively.
This report aims to provide a comprehensive presentation of the global market for Lumpectomy Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lumpectomy Therapy.
Report Scope
The Lumpectomy Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lumpectomy Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lumpectomy Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hologic
BD
Danaher
Cook Medical
Carl Zeiss Meditech
Merit Medical
Argon Medical Devices
Eckert & Ziegler
Theragenics
Sanarus
IsoAid
SOMATEX Medical
Ranfac
STERYLAB
Endomagnetics
Segment by Type
Lumpectomy Systems
Lumpectomy Surgical Tools
Segment by Application
Hospitals
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lumpectomy Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lumpectomy Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Lumpectomy Systems
1.2.3 Lumpectomy Surgical Tools
1.3 Market by Application
1.3.1 Global Lumpectomy Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lumpectomy Therapy Market Perspective (2019-2030)
2.2 Lumpectomy Therapy Growth Trends by Region
2.2.1 Global Lumpectomy Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Lumpectomy Therapy Historic Market Size by Region (2019-2024)
2.2.3 Lumpectomy Therapy Forecasted Market Size by Region (2025-2030)
2.3 Lumpectomy Therapy Market Dynamics
2.3.1 Lumpectomy Therapy Industry Trends
2.3.2 Lumpectomy Therapy Market Drivers
2.3.3 Lumpectomy Therapy Market Challenges
2.3.4 Lumpectomy Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lumpectomy Therapy Players by Revenue
3.1.1 Global Top Lumpectomy Therapy Players by Revenue (2019-2024)
3.1.2 Global Lumpectomy Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Lumpectomy Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lumpectomy Therapy Revenue
3.4 Global Lumpectomy Therapy Market Concentration Ratio
3.4.1 Global Lumpectomy Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lumpectomy Therapy Revenue in 2023
3.5 Lumpectomy Therapy Key Players Head office and Area Served
3.6 Key Players Lumpectomy Therapy Product Solution and Service
3.7 Date of Enter into Lumpectomy Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lumpectomy Therapy Breakdown Data by Type
4.1 Global Lumpectomy Therapy Historic Market Size by Type (2019-2024)
4.2 Global Lumpectomy Therapy Forecasted Market Size by Type (2025-2030)
5 Lumpectomy Therapy Breakdown Data by Application
5.1 Global Lumpectomy Therapy Historic Market Size by Application (2019-2024)
5.2 Global Lumpectomy Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Lumpectomy Therapy Market Size (2019-2030)
6.2 North America Lumpectomy Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Lumpectomy Therapy Market Size by Country (2019-2024)
6.4 North America Lumpectomy Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lumpectomy Therapy Market Size (2019-2030)
7.2 Europe Lumpectomy Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Lumpectomy Therapy Market Size by Country (2019-2024)
7.4 Europe Lumpectomy Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lumpectomy Therapy Market Size (2019-2030)
8.2 Asia-Pacific Lumpectomy Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Lumpectomy Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Lumpectomy Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lumpectomy Therapy Market Size (2019-2030)
9.2 Latin America Lumpectomy Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Lumpectomy Therapy Market Size by Country (2019-2024)
9.4 Latin America Lumpectomy Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lumpectomy Therapy Market Size (2019-2030)
10.2 Middle East & Africa Lumpectomy Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Lumpectomy Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Lumpectomy Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hologic
11.1.1 Hologic Company Detail
11.1.2 Hologic Business Overview
11.1.3 Hologic Lumpectomy Therapy Introduction
11.1.4 Hologic Revenue in Lumpectomy Therapy Business (2019-2024)
11.1.5 Hologic Recent Development
11.2 BD
11.2.1 BD Company Detail
11.2.2 BD Business Overview
11.2.3 BD Lumpectomy Therapy Introduction
11.2.4 BD Revenue in Lumpectomy Therapy Business (2019-2024)
11.2.5 BD Recent Development
11.3 Danaher
11.3.1 Danaher Company Detail
11.3.2 Danaher Business Overview
11.3.3 Danaher Lumpectomy Therapy Introduction
11.3.4 Danaher Revenue in Lumpectomy Therapy Business (2019-2024)
11.3.5 Danaher Recent Development
11.4 Cook Medical
11.4.1 Cook Medical Company Detail
11.4.2 Cook Medical Business Overview
11.4.3 Cook Medical Lumpectomy Therapy Introduction
11.4.4 Cook Medical Revenue in Lumpectomy Therapy Business (2019-2024)
11.4.5 Cook Medical Recent Development
11.5 Carl Zeiss Meditech
11.5.1 Carl Zeiss Meditech Company Detail
11.5.2 Carl Zeiss Meditech Business Overview
11.5.3 Carl Zeiss Meditech Lumpectomy Therapy Introduction
11.5.4 Carl Zeiss Meditech Revenue in Lumpectomy Therapy Business (2019-2024)
11.5.5 Carl Zeiss Meditech Recent Development
11.6 Merit Medical
11.6.1 Merit Medical Company Detail
11.6.2 Merit Medical Business Overview
11.6.3 Merit Medical Lumpectomy Therapy Introduction
11.6.4 Merit Medical Revenue in Lumpectomy Therapy Business (2019-2024)
11.6.5 Merit Medical Recent Development
11.7 Argon Medical Devices
11.7.1 Argon Medical Devices Company Detail
11.7.2 Argon Medical Devices Business Overview
11.7.3 Argon Medical Devices Lumpectomy Therapy Introduction
11.7.4 Argon Medical Devices Revenue in Lumpectomy Therapy Business (2019-2024)
11.7.5 Argon Medical Devices Recent Development
11.8 Eckert & Ziegler
11.8.1 Eckert & Ziegler Company Detail
11.8.2 Eckert & Ziegler Business Overview
11.8.3 Eckert & Ziegler Lumpectomy Therapy Introduction
11.8.4 Eckert & Ziegler Revenue in Lumpectomy Therapy Business (2019-2024)
11.8.5 Eckert & Ziegler Recent Development
11.9 Theragenics
11.9.1 Theragenics Company Detail
11.9.2 Theragenics Business Overview
11.9.3 Theragenics Lumpectomy Therapy Introduction
11.9.4 Theragenics Revenue in Lumpectomy Therapy Business (2019-2024)
11.9.5 Theragenics Recent Development
11.10 Sanarus
11.10.1 Sanarus Company Detail
11.10.2 Sanarus Business Overview
11.10.3 Sanarus Lumpectomy Therapy Introduction
11.10.4 Sanarus Revenue in Lumpectomy Therapy Business (2019-2024)
11.10.5 Sanarus Recent Development
11.11 IsoAid
11.11.1 IsoAid Company Detail
11.11.2 IsoAid Business Overview
11.11.3 IsoAid Lumpectomy Therapy Introduction
11.11.4 IsoAid Revenue in Lumpectomy Therapy Business (2019-2024)
11.11.5 IsoAid Recent Development
11.12 SOMATEX Medical
11.12.1 SOMATEX Medical Company Detail
11.12.2 SOMATEX Medical Business Overview
11.12.3 SOMATEX Medical Lumpectomy Therapy Introduction
11.12.4 SOMATEX Medical Revenue in Lumpectomy Therapy Business (2019-2024)
11.12.5 SOMATEX Medical Recent Development
11.13 Ranfac
11.13.1 Ranfac Company Detail
11.13.2 Ranfac Business Overview
11.13.3 Ranfac Lumpectomy Therapy Introduction
11.13.4 Ranfac Revenue in Lumpectomy Therapy Business (2019-2024)
11.13.5 Ranfac Recent Development
11.14 STERYLAB
11.14.1 STERYLAB Company Detail
11.14.2 STERYLAB Business Overview
11.14.3 STERYLAB Lumpectomy Therapy Introduction
11.14.4 STERYLAB Revenue in Lumpectomy Therapy Business (2019-2024)
11.14.5 STERYLAB Recent Development
11.15 Endomagnetics
11.15.1 Endomagnetics Company Detail
11.15.2 Endomagnetics Business Overview
11.15.3 Endomagnetics Lumpectomy Therapy Introduction
11.15.4 Endomagnetics Revenue in Lumpectomy Therapy Business (2019-2024)
11.15.5 Endomagnetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
